Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,618 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Synergistic prognostic values of cardiac sympathetic innervation with left ventricular hypertrophy and left atrial size in heart failure patients without reduced left ventricular ejection fraction: a cohort study.
Doi T, Nakata T, Hashimoto A, Yuda S, Wakabayashi T, Kouzu H, Kaneko N, Hase M, Tsuchihashi K, Miura T. Doi T, et al. Among authors: wakabayashi t. BMJ Open. 2012 Nov 30;2(6):e001015. doi: 10.1136/bmjopen-2012-001015. Print 2012. BMJ Open. 2012. PMID: 23204136 Free PMC article.
Cardiac metaiodobenzylguanidine activity can predict the long-term efficacy of angiotensin-converting enzyme inhibitors and/or beta-adrenoceptor blockers in patients with heart failure.
Nakata T, Wakabayashi T, Kyuma M, Takahashi T, Tsuchihashi K, Shimamoto K. Nakata T, et al. Among authors: wakabayashi t. Eur J Nucl Med Mol Imaging. 2005 Feb;32(2):186-94. doi: 10.1007/s00259-004-1624-8. Epub 2004 Sep 25. Eur J Nucl Med Mol Imaging. 2005. PMID: 15452671 Clinical Trial.
Predicting the need for an implantable cardioverter defibrillator using cardiac metaiodobenzylguanidine activity together with plasma natriuretic peptide concentration or left ventricular function.
Nagahara D, Nakata T, Hashimoto A, Wakabayashi T, Kyuma M, Noda R, Shimoshige S, Uno K, Tsuchihashi K, Shimamoto K. Nagahara D, et al. Among authors: wakabayashi t. J Nucl Med. 2008 Feb;49(2):225-33. doi: 10.2967/jnumed.107.042564. Epub 2008 Jan 16. J Nucl Med. 2008. PMID: 18199625 Free article. Clinical Trial.
Clinical implications of midventricular obstruction and intravenous propranolol use in transient left ventricular apical ballooning (Tako-tsubo cardiomyopathy).
Yoshioka T, Hashimoto A, Tsuchihashi K, Nagao K, Kyuma M, Ooiwa H, Nozawa A, Shimoshige S, Eguchi M, Wakabayashi T, Yuda S, Hase M, Nakata T, Shimamoto K. Yoshioka T, et al. Among authors: wakabayashi t. Am Heart J. 2008 Mar;155(3):526.e1-7. doi: 10.1016/j.ahj.2007.10.042. Epub 2008 Jan 18. Am Heart J. 2008. PMID: 18294491
Persistent insulin-sensitizing effects of sarpogrelate hydrochloride, a serotonin 2A receptor antagonist, in patients with peripheral arterial disease.
Kokubu N, Tsuchihashi K, Yuda S, Hase M, Eguchi M, Wakabayashi T, Hashimoto A, Nakata T, Miura T, Ura N, Nagao K, Tsuzuki M, Wakabayashi C, Shimamoto K. Kokubu N, et al. Among authors: wakabayashi c, wakabayashi t. Circ J. 2006 Nov;70(11):1451-6. doi: 10.1253/circj.70.1451. Circ J. 2006. PMID: 17062970 Free article. Clinical Trial.
1,618 results